过敏性紫癜患儿血清中IgA1半乳糖基的缺失水平及临床意义

过敏性紫癜患儿血清中IgA1半乳糖基的缺失水平及临床意义袁芳;胡筱;王飞飞;刘兰波;殷蕾;莫茜;金燕樑
【期刊名称】《临床儿科杂志》
【年(卷),期】2014(000)010
【摘要】Objective To explore the association of galactose-deifcient IgA1 levels with clinical features, and further to provide guidance for individualized treatment of HSP. Methods According to the clinical symptoms and curative effect, 57 children with HSP were divided into four groups:non-HSPN group (n=26), HSPN group (n=7), refractory HSP group (n=7) and remission group (n=17). In non-HSPN group, 12 cases received glucorticoid therapy and 14 cases did not. Serum galactose-de-ifcient IgA1 (Gd-IgA1) concentrations were detected using a Helix aspersa-lectin-based enzyme-linked immunosorbent assay (ELISA), and the total IgA1 levels were measured by ELISA. Results The serum Gd-IgA1 level was signiifcantly higher in 40 HSP children who were not cured than that in remission group and control group (P<0.05). However, there was no difference in Gd-IgA1 level between remission group and control group (P>0.05). Compared with the control group, the serum Gd-IgA1 level was signiifcantly higher in HSPN group, non-HSPN group and refractory HSP, and children with refractory HSP had signiifcantly higher Gd-IgA1 level than children in non-HSPN group (P<0.05). No signiifcant difference in Gd-IgA1 level was found either between HSPN group and refractory HSP group or between HSPN
group and non-HSPN group (P>0.05). Furthermore, in non-HSPN group, the serum Gd-IgA1 level in HSP children who were not treated with glucorticoid was signiifcantly higher than that in HSP children treated with glucorticoid (P<0.05). Conclusions The serum Gd-IgA1 level is associated with the disease activ-ity and curative effect of HSP, especially in children with refractory HSP, and it is thus likely to be a new non-invasive disease activity marker for guiding the proper usage of glucocorticoid and immunosuppressants in HSP children.%目的：探讨过敏性紫癜((Henoch-
Schönlein purpura，HSP)患儿血清IgA1半乳糖基的缺失水平与其临床特点的相关性，以指导临床个体化治疗。

方法根据临床症状和疗效将57例HSP患儿分为：非紫癜肾普通组(26例)，包括已激素治疗(12例)和尚未激素治疗者(14例)；HSP
肾病组(7例)；难治性HSP组(7例)；治愈组(17例)。

另选健康体检儿童24例作
为对照值。

以凝集素(lectin)亲和ELISA法及IgA1抗体亲和ELISA法分别检测HSP患儿和对照组血清IgA1半乳糖基的缺失水平及IgA1水平。

结果57例HSP 患儿中，40例未治愈者的血清IgA1半乳糖基缺失水平均高于治愈组和对照组，
差异有统计学意义(P均<0.05)；而治愈组与对照组间的差异无统计学意义
(P>0.05)。

在HSP的各亚组中，HSP肾病组、非紫癜肾普通组和难治性HSP组
的血清IgA1半乳糖基缺失水平均高于对照组；难治性HSP组高于非紫癜肾普通组，差异有统计学意义(P均<0.05)。

HSP肾病组与难治性HSP组及与非紫癜肾普通组患儿间血清IgA1半乳糖基缺失水平的差异无统计学意义(P均>0.05)。

非紫癜肾普通组中，尚未激素治疗组血清IgA1半乳糖基缺失水平高于已予激素治疗组，差异有统计学意义(P<0.05)。

结论 IgA1半乳糖基的缺失水平可以客观反映HSP
的疾病活动状况和疗效预期，尤其对于难治性HSP患儿，有望成为临床有效的生
物监测靶标以决策和指导糖皮质激素以及免疫抑制剂在HSP患儿中的合理使用。

【总页数】6页(P912-917)
【作者】袁芳;胡筱;王飞飞;刘兰波;殷蕾;莫茜;金燕樑
【作者单位】上海交通大学医学院附属上海儿童医学中心风湿科;上海交通大学医学院附属上海儿童医学中心风湿科;儿科转化医学研究所上海 200127;儿科转化医学研究所上海 200127;上海交通大学医学院附属上海儿童医学中心风湿科;儿科转化医学研究所上海 200127;上海交通大学医学院附属上海儿童医学中心风湿科; 儿科转化医学研究所上海 200127
【正文语种】中文
【相关文献】
1.过敏性紫癜肾炎患儿血清IgA1半乳糖水平的测定 [J], 蔡勇;蒋小云;陈述枚;张巧玲
2.过敏性紫癜血清中某些细胞因子和IgA1含量变化的临床意义 [J], 邢静;李文斌;刘振奎;石蔚
3.初诊过敏性紫癜患儿血清25羟维生素D水平变化及临床意义 [J], 华冉;邓芳;鹿玲;张琴;汪莉;高慧
4.过敏性紫癜患儿血清中IGF-1,PTX3和GAL-3水平及临床意义 [J], 熊承成;刘厚君;吴海燕
5.IgA肾病及过敏性紫癜性肾炎患儿血清半乳糖缺乏IgA_1测定的临床意义 [J], 邹敏书;余健;聂国明;尹晓玲;周建华
因版权原因，仅展示原文概要，查看原文内容请购买。